Xtrackers II Target Mat. Sept 2031 EUR Corp. Bond UCITS ETF 1C

INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the Bloomberg MSCI Euro Corporate September 2031 SRI Index (index). DESCRIPTION OF INDEX: The index aims to reflect the performance of the investment grade, euro-denominated, fixed-rate corporate bond market with maturity dates on or between 1 October 2030 and 30 September 2031, and excluding bonds which do not fulfil specific ESG criteria. The bonds must meet certain sector, amount outstanding, and security type criteria. From 1 October 2030, the Reference Index will also include certain Euro-denominated Treasury bills issued by certain European governments with 1 to 3 months remaining to maturity, and which fulfil certain ESG criteria (bills). ESG CRITERIA: Based on MSCI ESG Research, the index excludes: (i) sovereign issuers rated below BB or, (ii) corporate issuers rated below B, (iii) corporate issuers with a "red" Controversies score, (iv) corporate issuers breaching certain thresholds in controversial activities, and (v) Sovereign issuers classified as "Not Free" or "Partly Free" based on Freedom House data. INDEX REBALANCING, CALCULATION AND ADMINISTRATION: The weight of each corporate issuer is limited to 3%. From the 1 October 2030 cash amounts received from maturing bonds will be re-invested into bills rather than corporate bonds at each rebalance. The index is rebalanced monthly. The index is administered by Bloomberg Index Services Limited. The index is calculated on a total return basis which means that the payments from coupons are reinvested. INVESTMENT POLICY: To achieve the aim, the fund will attempt to replicate the index, before fees and expenses, by buying a portfolio of securities that may comprise the constituents of the index or other unrelated investments as determined by DWS entities. The fund may employ techniques and instruments in order to manage risk, reduce costs and improve results. These techniques and instruments may include the use of derivatives. F

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No